Eagle Capital Management initiated a new position in MercadoLibre (NASDAQ:MELI), acquiring 411,549 shares in the fourth quarter, according to a February 17, 2026, SEC filing. What happened According to an SEC filing dated February 17, 2026, Eagle Capital Management opened a new stake in MercadoLibre, acquiring 411,549 shares. At quarter-end, the position was valued at $828.97 million, reflecting the initial acquisition and changes in share price during the period. What else to know This is a new posit ...

CRISPR Therapeutics (NASDAQ: CRSP) is a company that can potentially help revolutionize healthcare. Its gene-editing therapies can be game changers for patients living with illnesses and conditions that might otherwise be difficult to treat. The company already has a promising approved therapy in Casgevy, which regulators first approved in 2023 to treat patients with sickle cell disease. It has also obtained approval as a treatment for transfusion-dependent beta thalassemia. Will AI create the world's fir ...

The fourth-quarter earnings season continues this week with reports from several major retailers, tech firms and software giants. AVGO stock is moving. See the chart and price action here. Here's a look at the earnings schedule for the week ahead: Monday, Mar. 2After Market Close:Retail investors will be watching AST SpaceMobile, Inc. (NASDAQ:ASTS) when it reports Q4 results after Monday's closing bell. Wall Street is anticipating quarterly losses of 16 cents per share on revenue of $41.11 million, accordin ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, as its valuation hovers around $1 trillion. It has generated fantastic gains for investors, rising by more than 400% in just the past five years. Those are terrific returns for a stock that's a fairly safe blue chip investment. But with such impressive gains, you may be wondering whether it's too late to invest in the stock, whether there's still room for it to rise, or if it's due for a correction. Below, I'll look to answer thos ...

Duolingo (NASDAQ: DUOL) has already proven it can scale up. The language-learning platform now serves more than 50 million daily active users and generates over $1 billion in annual revenue. It has transitioned from a high-growth start-up to a profitable subscription business. The next three years won't determine whether Duolingo survives. They will determine what kind of company it becomes. Will it evolve into a durable learning platform powered by artificial intelligence (AI), with expanding margins? Or ...

Big Investing Tips When Looking For Marijuana StocksThe cannabis industry is always working its way uphill when it comes to any form of success. To be more specific, due to the legal landscape in most legal markets, sustaining profitability while staying consistent with quality products is a battle. For example, having the right machinery or setup to produce and expand on new and existing cannabis products continuously.No, some companies have taken the path of forming strategic partnerships to meet the prod ...

For years, UnitedHealth Group (NYSE: UNH) stock has been a terrific growth investment. In fact, it looked unstoppable. Not only did it repeatedly grow its dividend, but the stock was amassing some outstanding results along the way. It was looking like the ultimate healthcare stock to own for the long term. But things have changed drastically for UnitedHealth Group within just the past 12 months. Concerns about rising costs and investigations into its billing practices have significantly weighed on its va ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Viewpoint - Micron Technology, Inc. is a leading player in the semiconductor industry, specializing in memory and storage solutions, particularly DRAM and NAND flash memory products, competing with major companies like Samsung and SK Hynix [1] Analyst Ratings and Price Targets - Brian Chin from Stifel Nicolaus has set a price target of $550 for Micron, indicating a potential increase of 33.38% from its current price of $412.37, which aligns with the consensus "Buy" rating from thirty-eight research firms [2][6] - Among the thirty-eight research firms, there are three "hold" ratings, twenty-nine "buy" ratings, and six "strong buy" ratings, with an average twelve-month price target of approximately $358, reflecting varied expectations among analysts [3] - Royal Bank of Canada has initiated coverage on Micron with an "outperform" rating and a price target of $425, while HSBC has raised its price target from $350 to $500, maintaining a "buy" rating [4] Current Stock Performance - Micron's current stock price is $412.37, reflecting a decrease of $3.19 or -0.77%, with a trading range today between $401.20 and $417.91; over the past year, the stock reached a high of $455.50 and a low of $61.54 [5] - The company's market capitalization is approximately $464.13 billion, with a trading volume of 22,246,699 shares on the NASDAQ exchange [5]

These days, home ownership is far from your only option when it comes to investing in real estate. Besides, the median down payment on a home as of December was $68,000 according to Redfin (5) — down 1.5% — but still a significant chunk of change. And that’s before you start thinking about the next 30 years of mortgage payments.That is great advice. But if you’re still drawn to the real estate market, some amount of leverage is often essential for most Americans, particularly those looking to buy a home.In ...